Among those with tumor progression during 2L CPI therapy, 41 patients received subsequent tumor treatment with an overall number of 70 treatment lines, which comprised the re-introduction of BRAF ± MEKi (n = 39), CPI (n = 29) or chemotherapy (n = 2). Here, BRAF is linked to neoplasm.